UTRIM

Lipid nanoparticles for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing surface chemistry for attachment of any protein, peptide or molecule to bind proteins of interest for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, and metabolic disorders; Biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders; Reagents for scientific research and medical research use; Chemical reagents other than for medical purposes; Diagnostic reagents for clinical or medical laboratory use; chemistry reagents for scientific research and medical research use; Reagents comprised of nanoparticles for scientific research and medical research use; Reagents, comprised of capsids for scientific research and medical research use; Reagents, namely, lipid nanoparticles, for scientific research and medical research use

Pharmaceutical product, namely, lipid nanoparticles, for medicinal use; Pharmaceutical preparations, namely, a lipid-enabled drug for binding to agents of interest (viruses, bacteria, free-circulating proteins in the body); Biological blocking agents in the form of lipid nanoparticles that facilitate the binding of viruses, bacteria, protein of interest in biological fluids; Pharmaceutical preparations for the treatment of diseases and disorders, namely, allergies, autoimmune diseases, cancer, cardiovascular diseases, genetic diseases, hematological diseases, infectious diseases, inflammatory diseases, metabolic diseases, neurological diseases, ocular diseases or respiratory diseases